Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults

Overview of attention for article published in BMC Health Services Research, January 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

So far, Altmetric has seen 3 X posts from 1 X users, with an upper bound of 23,109 followers.

Cost-effectiveness of adding rituximab to splenectomy & romiplostim in steroid-resistant ITP - Kikuchi et al. 2015 https://t.co/y9XxM83vCs

Cost-effectiveness of adding rituximab to splenectomy & romiplostim in steroid-resistant ITP - Kikuchi et al. 2015 http://t.co/eEXgl4IlgA

Cost-effectiveness of adding rituximab to splenectomy & romiplostim in steroid-resistant ITP - Kikuchi et al. 2015 http://t.co/y9XxM83vCs